Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in Metastatic Urothelial Cancer
NCT02334527Phase 2Terminated
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in urothelial carcinoma (UC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Mar 2015; status: terminated.
02
Drugs
palbociclib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT02334527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334527.